Table 2

User prevalence and prescription prevalence and in an inpatient setting by therapeutic level: prevalence per 1000 persons

Class*Korea (AUSOM)Hong Kong (CDARS)Japan (JMDC)Taiwan (NHIRD)
User prevalence
(%)†
Prescription prevalence (%)‡User prevalence (%)†Prescription prevalence (%)‡User prevalence (%)†Prescription prevalence (%)‡User prevalence (%)†Prescription prevalence (%)‡
Analgesics (including NSAIDs)109 (23)1269 (23)131 (36)314 (19)31 (19)380 (24)43 (25)195 (23)
Antibiotics107 (22)1141 (20)91 (25)634 (37)43 (26)496 (31)37 (21)233 (27)
Adrenergics65 (14)520 (9)31 (9)101 (6)23 (14)161 (10)23 (13)110 (13)
Antihistamines53 (11)520 (9)55 (15)136 (8)11 (7)48 (3)23 (13)77 (9)
Mucolytics53 (11)614 (11)4 (1)7 (0)22 (13)168 (11)19 (11)69 (8)
Corticosteroids45 (9)425 (8)21 (6)89 (5)15 (9)89 (6)18 (10)72 (8)
Anti-infectives (excluding antibiotics and vaccines)9 (2)130 (2)14 (4)48 (3)2 (1)28 (2)2 (1)15 (2)
Antiepileptics8 (2)431 (8)3 (1)36 (2)2 (1)27 (2)2 (1)23 (3)
Diuretics8 (2)170 (3)3 (1)39 (2)2 (1)42 (3)2 (1)14 (2)
Anticlotting and antifibrinolytic agents7 (1)188 (3)1 (0)25 (1)12 (7)99 (6)2 (1)8 (1)
Antidiabetic drugs4 (1)19 (0)0 (0)7 (0)1 (1)4 (0)1 (1)5 (1)
Psychotherapeutic agents2 (0)65 (1)3 (1)138 (8)2 (1)17 (1)1 (1)14 (2)
Antineoplastic and immunomodulating agents2 (0)100 (2)1 (0)61 (4)1 (1)26 (2)0 (0)14 (2)
Central nervous system stimulants1 (0)20 (0)2 (1)62 (4)0 (0)2 (0)0 (0)3 (0)
Contraceptives0 (0)2 (0)0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)
Total473 (100%)5614 (100%)360 (100%)1697 (100%)167 (100%)1587 (100%)173 (100%)852 (100%)
  • *Custom classification, see online supplementary material 1.

  • †For all 15 different drug classes, the prevalence per 1000 persons was calculated as % of the total country-specific user prevalence (class-specific user prevalence/total user prevalence).

  • ‡For all 15 different drug classes, the prevalence per 1000 persons was calculated as % of the total country-specific prescription prevalence (class-specific prescription prevalence/total prescription prevalence).

  • AUSOM, the South Korean Ajou University School of Medicine; CDARS, the Hong Kong Clinical Data Analysis and Reporting System; JMDC, the Japan Medical Data Center ; NHIRD, Taiwan’s National Health Insurance Research Database; NSAID, non-steroidal anti-inflammatory drug.